A federal track-and-trace system should be created by Congress to shield patients from potentially deadly, counterfeit and illicit drugs, Grace-Marie Turner writes. A federally established standard would in the long run save money for drugmakers and their consumers, while a state-by-state system would be difficult to navigate and wouldn't work, she writes.

Full Story:

Related Summaries